These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 14962751

  • 1. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.
    Sassoon J, Daniels M, Brown DR.
    Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751
    [Abstract] [Full Text] [Related]

  • 2. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
    Bai Y, Li Q, Yang J, Zhou X, Yin X, Zhao D.
    Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
    [Abstract] [Full Text] [Related]

  • 3. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I, Zorzi W, Rachidi W, Zorzi D, Pierard O, Lhereux B, Heinen E, Elmoualij B.
    J Neurosci Res; 2006 Aug 15; 84(3):637-46. PubMed ID: 16786576
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
    Stewart LR, White AR, Jobling MF, Needham BE, Maher F, Thyer J, Beyreuther K, Masters CL, Collins SJ, Cappai R.
    J Neurosci Res; 2001 Sep 15; 65(6):565-72. PubMed ID: 11550224
    [Abstract] [Full Text] [Related]

  • 5. Selective blockade of astrocytic glutamate transporter GLT-1 with dihydrokainate prevents neuronal death during ouabain treatment of astrocyte/neuron cocultures.
    Kawahara K, Hosoya R, Sato H, Tanaka M, Nakajima T, Iwabuchi S.
    Glia; 2002 Dec 15; 40(3):337-49. PubMed ID: 12420313
    [Abstract] [Full Text] [Related]

  • 6. Mouse galectin-1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression.
    Lekishvili T, Hesketh S, Brazier MW, Brown DR.
    Eur J Neurosci; 2006 Dec 15; 24(11):3017-25. PubMed ID: 17156363
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
    Ning ZY, Zhao DM, Liu HX, Yang JM, Han CX, Cui YL, Meng LP, Wu CD, Liu ML, Zhang TX.
    Cell Mol Neurobiol; 2005 Dec 15; 25(8):1171-83. PubMed ID: 16388330
    [Abstract] [Full Text] [Related]

  • 8. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA.
    Hippocampus; 2006 Dec 15; 16(10):834-42. PubMed ID: 16897723
    [Abstract] [Full Text] [Related]

  • 9. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
    Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Pillot T.
    Mol Cell Neurosci; 2004 Jan 15; 25(1):95-102. PubMed ID: 14962743
    [Abstract] [Full Text] [Related]

  • 10. Prion protein peptide neurotoxicity can be mediated by astrocytes.
    Brown DR.
    J Neurochem; 1999 Sep 15; 73(3):1105-13. PubMed ID: 10461901
    [Abstract] [Full Text] [Related]

  • 11. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
    Brown DR.
    Mol Cell Neurosci; 2000 Jan 15; 15(1):66-78. PubMed ID: 10662506
    [Abstract] [Full Text] [Related]

  • 12. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
    Abulrob A, Tauskela JS, Mealing G, Brunette E, Faid K, Stanimirovic D.
    J Neurochem; 2005 Mar 15; 92(6):1477-86. PubMed ID: 15748165
    [Abstract] [Full Text] [Related]

  • 13. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
    Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM.
    Neurobiol Dis; 2006 Sep 15; 23(3):669-78. PubMed ID: 16844381
    [Abstract] [Full Text] [Related]

  • 14. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
    Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY.
    J Neurochem; 2008 Jul 15; 106(1):45-55. PubMed ID: 18346200
    [Abstract] [Full Text] [Related]

  • 15. Effect of NMDA receptor antagonist on proliferation of neurospheres from embryonic brain.
    Mochizuki N, Takagi N, Kurokawa K, Kawai T, Besshoh S, Tanonaka K, Takeo S.
    Neurosci Lett; 2007 May 01; 417(2):143-8. PubMed ID: 17403571
    [Abstract] [Full Text] [Related]

  • 16. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory.
    Simões PF, Silva AP, Pereira FC, Marques E, Grade S, Milhazes N, Borges F, Ribeiro CF, Macedo TR.
    Neuroscience; 2007 Dec 05; 150(2):433-41. PubMed ID: 17981398
    [Abstract] [Full Text] [Related]

  • 17. A model for the mechanism of astrogliosis in prion disease.
    Hafiz FB, Brown DR.
    Mol Cell Neurosci; 2000 Sep 05; 16(3):221-32. PubMed ID: 10995549
    [Abstract] [Full Text] [Related]

  • 18. AMPA and NMDA receptor-mediated currents in developing dentate gyrus granule cells.
    Ye GL, Yi S, Gamkrelidze G, Pasternak JF, Trommer BL.
    Brain Res Dev Brain Res; 2005 Mar 22; 155(1):26-32. PubMed ID: 15763272
    [Abstract] [Full Text] [Related]

  • 19. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
    Yang L, Zhou X, Yang J, Yin X, Han L, Zhao D.
    J Neuroimmunol; 2008 Aug 13; 199(1-2):10-7. PubMed ID: 18547651
    [Abstract] [Full Text] [Related]

  • 20. Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801.
    Brenner E, Kondziella D, Håberg A, Sonnewald U.
    J Neurochem; 2005 Sep 13; 94(6):1594-603. PubMed ID: 16045441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.